Literature DB >> 21654837

Infliximab infusions for Netherton syndrome: sustained clinical improvement correlates with a reduction of thymic stromal lymphopoietin levels in the skin.

Lionel Fontao, Emmanuel Laffitte, Anais Briot, Gürkan Kaya, Pascale Roux-Lombard, Sylvie Fraitag, Alain A Hovnanian, Jean-Hilaire Saurat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21654837     DOI： 10.1038/jid.2011.124

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  20 in total

1.  Ichthyosis molecular fingerprinting shows profound TH17 skewing and a unique barrier genomic signature.

Authors:  Kunal Malik; Helen He; Thy Nhat Huynh; Gary Tran; Kelly Mueller; Kristina Doytcheva; Yael Renert-Yuval; Tali Czarnowicki; Shai Magidi; Margaret Chou; Yeriel D Estrada; Huei-Chi Wen; Xiangyu Peng; Hui Xu; Xiuzhong Zheng; James G Krueger; Amy S Paller; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2018-05-24       Impact factor: 10.793

2.  [Generalised erythema, scaling and hair anomaly].

Authors:  C Hammer; N Voshege; U Hillen; J Dissemond
Journal:  Hautarzt       Date:  2013-07       Impact factor: 0.751

Review 3.  Profiling Immune Expression to Consider Repurposing Therapeutics for the Ichthyoses.

Authors:  Amy S Paller
Journal:  J Invest Dermatol       Date:  2019-01-19       Impact factor: 8.551

4.  Secukinumab Therapy for Netherton Syndrome.

Authors:  Isabelle Luchsinger; Nicole Knöpfel; Martin Theiler; Mathilde Bonnet des Claustres; Claire Barbieux; Agnes Schwieger-Briel; Corinne Brunner; Davide Donghi; Michael Buettcher; Barbara Meier-Schiesser; Alain Hovnanian; Lisa Weibel
Journal:  JAMA Dermatol       Date:  2020-08-01       Impact factor: 10.282

5.  An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis.

Authors:  Amy S Paller; Yael Renert-Yuval; Maria Suprun; Hitokazu Esaki; Margeaux Oliva; Thy Nhat Huynh; Benjamin Ungar; Norma Kunjravia; Rivka Friedland; Xiangyu Peng; Xiuzhong Zheng; Yeriel D Estrada; James G Krueger; Keith A Choate; Mayte Suárez-Fariñas; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2016-08-20       Impact factor: 10.793

Review 6.  Eosinophilia Associated with Disorders of Immune Deficiency or Immune Dysregulation.

Authors:  Kelli W Williams; Joshua D Milner; Alexandra F Freeman
Journal:  Immunol Allergy Clin North Am       Date:  2015-08       Impact factor: 3.479

Review 7.  Pathogenesis-based therapies in ichthyoses.

Authors:  Joey E Lai-Cheong; Peter M Elias; Amy S Paller
Journal:  Dermatol Ther       Date:  2013 Jan-Feb       Impact factor: 2.851

8.  Netherton syndrome caused by compound heterozygous mutation, c.80A>G mutation in SPINK5 and large-sized genomic deletion mutation, and successful treatment of intravenous immunoglobulin.

Authors:  Zhen Zhang; Chaolan Pan; Ruoqu Wei; Huaguo Li; Yijun Yang; Jiawen Chen; Ming Li; Zhirong Yao
Journal:  Mol Genet Genomic Med       Date:  2021-01-16       Impact factor: 2.183

9.  Cocktails of KLK5 Protease Inhibitors and Anti-TNFα Therapeutics: an Effective Treatment for Netherton Syndrome.

Authors:  Eleni Zingkou; Georgios Pampalakis; Georgia Sotiropoulou
Journal:  J Clin Immunol       Date:  2022-01-18       Impact factor: 8.317

Review 10.  Netherton Syndrome in Children: Management and Future Perspectives.

Authors:  Federica Barbati; Mattia Giovannini; Teresa Oranges; Lorenzo Lodi; Simona Barni; Elio Novembre; Ermanno Baldo; Mario Cristofolini; Stefano Stagi; Silvia Ricci; Francesca Mori; Cesare Filippeschi; Chiara Azzari; Giuseppe Indolfi
Journal:  Front Pediatr       Date:  2021-05-10       Impact factor: 3.418
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.